SEPN

SEPTERNA INC

SEPN·81734D104·US·Common Stock·Healthcare - Biotechnology-13D/G

SEPN (SEPTERNA INC) is held by 73 institutional investors as of Q1 2026. Largest holders: RA CAPITAL MANAGEMENT, L.P. ($168.1M), DRIEHAUS CAPITAL MANAGEMENT LLC ($105.6M), GOLDMAN SACHS GROUP INC ($69.8M). Net institutional sentiment: Mixed.

73
Holders
(5 Elite)
$589.2M
Total Value
63% (78)
Consensus
49 buying - 29 selling
13F: Insider & Congress:
SEPNSmart Money Verdict
View all
Held by 73 funds
5 elite
Who's Trading
InsiderBEBhatt ElizabethSell $61KApr 15, 2026
InsiderBEBhatt ElizabethSell $28KApr 15, 2026
InsiderBEBhatt ElizabethSell $8KApr 15, 2026
InsiderSSShaikhly SamiraSell $112KMar 2, 2026
InsiderSSShaikhly SamiraSell $1.9MMar 2, 2026
InsiderBEBhatt ElizabethSell $63KFeb 18, 2026
InsiderBEBhatt ElizabethSell $53KFeb 18, 2026
ActivistBVBIOTECHNOLOGY VALUE FUND L P2.0%Feb 17, 2026
InsiderLDLong Daniel D.Sell $63KNov 10, 2025
ActivistDRIEHAUS CAPITAL MANAGEMENT LLCDRIEHAUS CAPITAL MANAGEMENT LLC10.5%Jun 10, 2025
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
7M$168.1M1.8%+54.67%
0
Decreased
4.4M(-8.6%)$105.6M0.8%+110.13%
0
Increased
2.9M(+7.0%)$69.8M0.0%+41.13%
32
Increased
1.8M(+1.2%)$43.8M0.0%+56.07%
29
Unchanged
1.3M$32.1M0.3%+78.27%
0
New
1.2M$28.8M0.0%+27.73%
40
Increased
1M(+92.1%)$25.2M0.0%+28.56%
45
New
890,754$21.3M0.0%+27.73%
39
Increased
645,146(+12.6%)$15.5M0.0%+69.48%
32
Increased
631,447(+16.9%)$15.2M0.0%+63.63%
33
Increased
236,679(+6527.8%)$5.7M0.0%+27.75%
44
Increased
223,995(+0.6%)$5.4M0.0%+118.47%
27
New
195,043$4.7M0.0%+27.73%
37
Decreased
181,580(-3.0%)$4.4M0.0%+80.57%
0
Increased
164,530(+6.7%)$4M0.0%+61.80%
29
New
154,484$3.7M0.0%+27.73%
37
Increased
124,101(+15.5%)$3M0.0%+98.76%
30
Increased
116,979(+70.0%)$2.8M0.0%+72.00%
39
Increased
110,530(+6.3%)$2.7M0.0%+71.06%
28
Increased
89,301(+13.2%)$2.1M0.0%+29.15%
29

Showing 1-20 of 85

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used